Efficacy and safety of glecaprevir/pibrentasvir in renally impaired patients with chronic HCV infection.
Eric LawitzRobert FlisiakManal AbunimehMeghan E SiseJun Yong ParkMarwan KaskasAnnette BruchfeldMarcus-Alexander WörnsAndrea AglittiPhilippe J ZamorZhenyi XueGretja SchnellYash J JalundhwalaAriel PorcallaFederico J MensaMarcello PersicoPublished in: Liver international : official journal of the International Association for the Study of the Liver (2019)
This Phase 3 clinical trial was funded by AbbVie and registered with clinicaltrials.gov as NCT03069365 (EXPEDITION-5).